Jörge E. Cortes

6 ta ish

Tashkent Pediatric Medical Institute

1. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

   Michele Baccarani, Michael Deininger, Gianantonio Rosti +29

   Sharh maqolaOAOchiq kirish20133 iqtibos

   ABIABI:AkademIndex/2026.other.108143

2. The effects of imatinib on pregnancy outcome

   Seonaid Pye, Jörge E. Cortes, Patricia Ault +5

   MaqolaOAOchiq kirish20082 iqtibos

   ABIABI:AkademIndex/2026.other.108153

3. Successful Completion of Pregnancy in a Patient With Chronic Myeloid Leukemia Without Active Intervention: A Case Report and Review of the Literature

   Suzanne Cole, Hagop M. Kantarjian, Patricia Ault +1

   Sharh maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.108155

4. The impact of dasatinib on pregnancy outcomes

   Jörge E. Cortes, Elisabetta Abruzzese, Ekaterina Chelysheva +3

   MaqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.108162

5. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

   Jörge E. Cortes, Giuseppe Saglio, Hagop M. Kantarjian +9

   MaqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.108166

6. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial

   Jane F. Apperley, Jörge E. Cortes, Elias Jabbour +21

   MaqolaOAOchiq kirishChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

   ABIABI:AkademIndex/2023.article.010140